Bioprojet Deutschland

Bioprojet is a research-oriented pharmaceutical company founded in 1992 by researchers from INSERM, specializing in the discovery and development of novel therapeutic agents for unmet medical needs. The company is a pioneer in the field of histamine H3 receptor pharmacology, which led to the development of its flagship product, Wakix (pitolisant), for the treatment of narcolepsy and other sleep disorders. Bioprojet Deutschland GmbH serves as the group's German subsidiary, managing commercial operations, medical affairs, and distribution within the region. In addition to neurology, the company has a significant presence in gastroenterology with products like Tiorfan (racecadotril) for acute diarrhea. Bioprojet remains an independent, private entity that prioritizes high-unmet-need indications and orphan diseases. Its business model integrates internal research and development with strategic international partnerships for global commercialization.